DE69927125D1 - Zusammensetzung gegen Erhöhung oder zur Herabsetzung des Blutzuckerspiegels - Google Patents

Zusammensetzung gegen Erhöhung oder zur Herabsetzung des Blutzuckerspiegels

Info

Publication number
DE69927125D1
DE69927125D1 DE69927125T DE69927125T DE69927125D1 DE 69927125 D1 DE69927125 D1 DE 69927125D1 DE 69927125 T DE69927125 T DE 69927125T DE 69927125 T DE69927125 T DE 69927125T DE 69927125 D1 DE69927125 D1 DE 69927125D1
Authority
DE
Germany
Prior art keywords
blood sugar
sugar level
decrease
composition against
increase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69927125T
Other languages
English (en)
Other versions
DE69927125T2 (de
Inventor
Futoshi Matsuyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18405294&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69927125(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69927125D1 publication Critical patent/DE69927125D1/de
Publication of DE69927125T2 publication Critical patent/DE69927125T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DE69927125T 1998-12-09 1999-11-23 Zusammensetzung gegen Erhöhung oder zur Herabsetzung des Blutzuckerspiegels Expired - Fee Related DE69927125T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10349667A JP2000169384A (ja) 1998-12-09 1998-12-09 血糖値上昇抑制乃至下降用組成物
JP34966798 1998-12-09

Publications (2)

Publication Number Publication Date
DE69927125D1 true DE69927125D1 (de) 2005-10-13
DE69927125T2 DE69927125T2 (de) 2006-05-18

Family

ID=18405294

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69927125T Expired - Fee Related DE69927125T2 (de) 1998-12-09 1999-11-23 Zusammensetzung gegen Erhöhung oder zur Herabsetzung des Blutzuckerspiegels

Country Status (7)

Country Link
US (3) US6485760B2 (de)
EP (1) EP1022022B1 (de)
JP (1) JP2000169384A (de)
AT (1) ATE303805T1 (de)
DE (1) DE69927125T2 (de)
DK (1) DK1022022T3 (de)
ES (1) ES2245812T3 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60015847T2 (de) * 1999-05-25 2005-10-27 Use Techno Corp., Fukuchiyama Flüssige Zubereitung zum Verdampfen gegen Erhöhung des Blutzuckerspiegels und Verdampfer für dieselbe
US7713546B1 (en) * 2001-04-03 2010-05-11 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
WO2002043681A1 (en) * 2000-11-28 2002-06-06 Avon Products, Inc. Anti-aging cosmetic composition and method of application
JP2002255837A (ja) * 2001-03-01 2002-09-11 Mikimoto Pharmaceut Co Ltd アルドースレダクターゼ阻害剤
JP2005502666A (ja) * 2001-08-31 2005-01-27 オハイオ ユニバーシティー 高血糖症を有する被験体を処置するための組成物および方法
US6908632B1 (en) * 2002-04-19 2005-06-21 Pharmanex, Llc Blood glucose modulating compositions and methods
JP4094332B2 (ja) * 2002-04-23 2008-06-04 丸善製薬株式会社 水分散性又は水溶解性のバナバ葉抽出物組成物
JP2005029570A (ja) 2003-06-16 2005-02-03 Tokiwa Shokubutsu Kagaku Kenkyusho:Kk コロソリン酸の製造方法
JP2005126414A (ja) * 2003-09-11 2005-05-19 Kiyotoshi Oshiro 吸収を高める生薬成分含有組成物及びその製造方法。
US20050142270A1 (en) * 2003-09-22 2005-06-30 Use- Techno Corporation Functional sweetener
US20050137259A1 (en) * 2003-09-22 2005-06-23 Use- Techno Corporation Insulin secretion potentiator
US20070093552A1 (en) * 2003-09-22 2007-04-26 Futoshi Matsuyama Early insulin secretion stimulator
US20050143464A1 (en) * 2003-09-22 2005-06-30 Use-Techno Corporation Insulin secretion potentiator
US7125571B2 (en) 2003-11-25 2006-10-24 D & E Pharmaceuticals, Inc. Herbal formulation
US20050267055A1 (en) * 2003-12-26 2005-12-01 Use-Techno Corporation Agent for improvement of glucose tolerance
JPWO2005063228A1 (ja) * 2003-12-26 2007-07-19 株式会社ユース・テクノコーポレーション 耐糖能改善剤
US20050186269A1 (en) * 2004-02-25 2005-08-25 Udell Ronald G. Stabilized feverfew formulations
JP4922550B2 (ja) * 2004-03-16 2012-04-25 株式会社東洋新薬 コロソリン酸高含有バナバ葉抽出物の製造方法
TW200539820A (en) * 2004-04-15 2005-12-16 San Ei Gen Ffi Inc Process for preparing lagerstroemia speciosa L. extract
JP2005350453A (ja) * 2004-05-14 2005-12-22 Toyo Shinyaku:Kk バナバ葉の水難溶性成分
WO2006012015A2 (en) * 2004-06-29 2006-02-02 Oregon Health And Science University Methods and compositions for nerve regeneration
US20060051435A1 (en) * 2004-08-19 2006-03-09 Udell Ronald G Nutritional supplement for body fat reduction
CN1303096C (zh) * 2004-10-12 2007-03-07 中国药科大学 科罗索酸和山楂酸的制备方法
WO2006054370A1 (en) * 2004-11-16 2006-05-26 Use-Techno Corporation Gluconeogenesis inhibiting agent
US7574353B2 (en) * 2004-11-18 2009-08-11 Lsi Logic Corporation Transmit/receive data paths for voice-over-internet (VoIP) communication systems
KR20070108161A (ko) * 2004-12-22 2007-11-08 르네상스 허브즈 인코포레이티드 라거스트로에미아 스페시오사 엘. 식물로부터 유도된약학적, 치료적, 및 식이 조성물
US20090054522A1 (en) * 2005-02-22 2009-02-26 Maruzen Pharmaceuticals Co., Ltd. Hair Care Product
KR100693400B1 (ko) 2005-06-30 2007-03-09 주식회사 삼양제넥스 식물 세포 현탁 배양에 의한 코로솔릭산의 제조방법
KR100697184B1 (ko) 2006-01-06 2007-03-21 주식회사 농협고려인삼 인삼과 상엽과 바나바엽을 주재로 한 혈당강하용 기능성 식품 및 그 제조방법
US20070166321A1 (en) * 2006-01-13 2007-07-19 Bryant Villeponteau Compositions and Methods for Reducing Cholesterol and Inflammation
WO2007094497A1 (ja) * 2006-02-17 2007-08-23 Use-Techno Corporation メタボリックシンドローム改善剤
US9943409B2 (en) 2006-11-14 2018-04-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Transcatheter coronary sinus mitral valve annuloplasty procedure and coronary artery and myocardial protection device
WO2008060553A1 (en) 2006-11-14 2008-05-22 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Transcatheter coronary sinus mitral valve annuloplasty procedure and coronary artery and myocardial protection device
US7416750B1 (en) 2007-02-26 2008-08-26 Nbty, Inc. Composition to provide maintenance and nutritional support in glycemic control deficits
US20080268039A1 (en) * 2007-03-06 2008-10-30 Soft Gel Technologies, Inc. Loquat compositions
JP2013010715A (ja) * 2011-06-29 2013-01-17 Nippon Flour Mills Co Ltd う蝕予防剤、歯周病予防剤及び口腔用組成物
US11007059B2 (en) 2016-05-06 2021-05-18 Transmural Systems Llc Annuloplasty procedures, related devices and methods
US11980545B2 (en) 2016-05-06 2024-05-14 Transmural Systems Llc Annuloplasty procedures, related devices and methods
WO2019046205A1 (en) 2017-08-26 2019-03-07 Macdonald, Stuart ANNULOPLASTY AND CARDIAC STIMULATION PROCEDURES, DEVICES AND ASSOCIATED METHODS
US11039923B2 (en) 2016-05-06 2021-06-22 Transmural Systems Llc Annuloplasty procedures, related devices and methods
EP3451973A4 (de) 2016-05-06 2019-12-25 Transmural Systems LLC Annuloplastikeingriffe, zugehörige vorrichtungen und verfahren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4544550A (en) * 1982-10-05 1985-10-01 Rodolfo Almanzor Y Method for the treatment of diabetes
JPH05310587A (ja) 1992-03-11 1993-11-22 Itouen:Kk バナバ葉抽出物と使用方法並びに抗糖尿病剤
JP3507115B2 (ja) * 1994-02-18 2004-03-15 株式会社 伊藤園 バナバ葉抽出物と抗糖尿病剤
JP3507116B2 (ja) * 1994-02-18 2004-03-15 株式会社 伊藤園 コレステロール上昇抑制作用剤

Also Published As

Publication number Publication date
EP1022022A1 (de) 2000-07-26
US6485760B2 (en) 2002-11-26
EP1022022B1 (de) 2005-09-07
US20030008025A1 (en) 2003-01-09
ES2245812T3 (es) 2006-01-16
US6716459B2 (en) 2004-04-06
DE69927125T2 (de) 2006-05-18
ATE303805T1 (de) 2005-09-15
US20010006941A1 (en) 2001-07-05
JP2000169384A (ja) 2000-06-20
US20010000474A1 (en) 2001-04-26
DK1022022T3 (da) 2006-01-09

Similar Documents

Publication Publication Date Title
DE69927125D1 (de) Zusammensetzung gegen Erhöhung oder zur Herabsetzung des Blutzuckerspiegels
DK1251750T3 (da) Forbedret pædiatrisk formulering og fremgangsmåder til tilvejebringelse af ernæring og forbedring af tolerance
TW429145B (en) Pharmaceutical composition for treating schizophrenia, tardive dyskinesia, depression, and alzheimer's disease comprising EPA/SA
WO2003051380A3 (en) Compositions containeing curcuma extracts for the treatment of neurocerebrovascular disorders
UA90668C2 (ru) Состав для лечения хронической венозной недостаточности, который содержит водный экстракт листьев красного винограда и противовоспалительное средство
SE9803710L (sv) Användning av vissa substanser för behandling av nervrotsskador
WO2001070664A3 (en) Lipoxin analogs and methods for the treatment of periodontal disease
CA2271162A1 (en) Stearidonic acid compositions and uses thereof
PT1216041E (pt) Dieta com elevado teor de lipidos
ES2193112T3 (es) Metodo para el tratamiento de insuficiencias venosas cronicas utilizando un extracto de hojas de vid roja.
BR9914644A (pt) Composições tamponadas para diálise
WO1998032428A3 (en) Compositions comprising choline and use of choline to treat endotoxic shock
WO2002100404A3 (en) Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes
ATE258435T1 (de) Pinolensäure gegen diabetes
IL175358A0 (en) 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
EP1269991A3 (de) Topische Zusammensetzung die Ethyllinoleat und/oder Triethylzitrat mit Synergisten
WO1999059523A3 (en) Topical pharmaceutical compositions useful for the treatment of cutaneous or circulatory pathologies on inflammatory, immune, proliferative or degenerative basis
ITRM990707A0 (it) Composizione per la prevenzione e/o il trattamento di disturbi dovutiad un alterato metabolismo dei lipidi, che comprende propionil l-carni
AU2003290031A1 (en) Method of improvement of blood circulation
MXPA03004817A (es) Composicion dietetica conteniendo acido linoleico conjugado y calcio para salud mejorada.
DK1062954T3 (da) Anvendelse af itakonsyre til regulering af det glykotiske stofskifte
WO2000007541A3 (de) Verwendung von xanthinderivaten zur behandlung von erektionsstörungen
IL151878A0 (en) Pharmaceutical compositions containing t3
CA2427289A1 (en) Fat composition and hexacosanoic acid depressant for oral or enteral administration
DE69729729D1 (de) Arzneimittel zur anwendung im mund

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee